Safety and tolerance of Navelbine in phase I-II clinical studies.

作者信息

Besenval M, Delgado M, Demarez J P, Krikorian A

机构信息

Centre de recherche Pierre Fabre, Castres, France.

出版信息

Semin Oncol. 1989 Apr;16(2 Suppl 4):37-40.

PMID:2540533

Abstract

摘要

相似文献

Safety and tolerance of Navelbine in phase I-II clinical studies.

Semin Oncol. 1989 Apr;16(2 Suppl 4):37-40.

Navelbine in advanced ovarian epithelial cancer: a study of the French oncology centers.

Semin Oncol. 1989 Apr;16(2 Suppl 4):30-2.

Efficacy of Navelbine (NVB) in non-small cell lung cancer (NSCLC).

Semin Oncol. 1989 Apr;16(2 Suppl 4):26-9.

Phase-II study of Navelbine in advanced breast cancer.

Semin Oncol. 1989 Apr;16(2 Suppl 4):33-6.

Oral vinorelbine (Navelbine) in the treatment of advanced non-small cell lung cancer: a preliminary report.

Semin Oncol. 1994 Oct;21(5 Suppl 10):35-8; discussion 38-41.

A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.

Am J Clin Oncol. 1982 Feb;5(1):49-52.

Pilot study of vinorelbine (navelbine) and paclitaxel in patients with refractory non-small cell lung cancer.

Semin Oncol. 1996 Apr;23(2 Suppl 5):19-21.

A summary of vinorelbine (Navelbine) safety data from North American clinical trials.

Semin Oncol. 1994 Oct;21(5 Suppl 10):42-6; discussion 46-7.

[Studies of the clinical use of cycloplatin--a new derivative of cisplatin].

Przegl Lek. 1992;49(4):120-2.

[Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].

Gan To Kagaku Ryoho. 1983 Aug;10(8):1838-43.

引用本文的文献

Concurrent use of vinorelbine and gefitinib induces supra-additive effect in head and neck squamous cell carcinoma cell lines.

J Cancer Res Clin Oncol. 2007 Mar;133(3):169-76. doi: 10.1007/s00432-006-0154-0. Epub 2006 Oct 5.

Vinorelbine--a clinical review.

Br J Cancer. 2000 Jun;82(12):1907-13. doi: 10.1054/bjoc.2000.1203.

Clinical phase I and pharmacokinetic trial of vinorelbine administered as single intravenous bolus every 21 days in cancer patients.

Invest New Drugs. 1996;14(4):371-8. doi: 10.1007/BF00180813.

Vinorelbine: an active, non cross-resistant drug in advanced breast cancer. Results from a phase II study.

Breast Cancer Res Treat. 1996;39(3):285-91. doi: 10.1007/BF01806156.

Vinorelbine and the topoisomerase 1 inhibitors: current and potential roles in breast cancer chemotherapy.

Breast Cancer Res Treat. 1995;33(1):1-17. doi: 10.1007/BF00666066.

Overview of new treatments for breast cancer.

Breast Cancer Res Treat. 1992;21(1):3-13. doi: 10.1007/BF01811959.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验